The Journal of Pain
Volume 10, Issue 2 , Pages 191-200 , February 2009

Diclofenac Potassium Attenuates Dysmenorrhea and Restores Exercise Performance in Women With Primary Dysmenorrhea

  • Ingrid Chantler

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Ingrid Chantler, Brain Function Research Group, School of Physiology, University of Witwatersrand, 7 York Road, Parktown, 2193, Johannesburg, South Africa
    • ,
  • Duncan Mitchell
    • ,
  • Andrea Fuller

Received 29 April 2008 ,Revised 15 August 2008 ,Accepted 26 August 2008.

References 

  1. Andersch B, Milsom I. An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol. 1982;144:655–660
  2. Biegelmayer C, Hofer G, Kainz C, Reinthaller A, Kopp B, Janisch H. Concentrations of various arachidonic acid metabolites in menstrual fluid are associated with menstrual pain and are influenced by hormonal contraceptives. Gynecol Endocrinol. 1995;9:307–312
  3. Bale P, Davis J. Effect of menstruation and contraceptive pill on the performance of physical education students. Br J Sports Med. 1983;17:46–50
  4. Bale P, Nelson G. The effects of menstruation on performance of swimmers. AJSMS. 1985;3:19–22
  5. Banikarim C, Chacko MR, Kelder SH. Prevalence and impact of dysmenorrhoea on Hispanic female adolescents. Arch Paediatr Adolesc Med. 2000;154:1226–1229
  6. Borg GA. Perceived exertion: a note on “history” and methods. Med Sci Sports Exerc. 1973;5:90–93
  7. Burnett MA, Antao V, Black A, Feldman K, Grenville A, Lea R, et al. Prevalence of primary dysmenorrhea in Canada. J Obstet Gynecol Can. 2005;27:765–770
  8. Chantler I, Mitchell D, Fuller A. The effect of three cyclo-oxygenase inhibitors on intensity of primary dysmenorrheic pain. Clin J Pain. 2008;24:39–44
  9. Coco AS. Primary dysmenorrhea. Am Fam Physician. 1999;60:489–496
  10. Collins SL, Moore RA, McQuay HJ. The visual analog pain intensity scale: What is moderate pain in millimeters?. Pain. 1997;72:95–97
  11. Daniels SE, Talwalker S, Torri S, Snabes MC, Recker DP, Verburg KM. Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea. Obstet Gynecol. 2002;100:350–358
  12. Davis AR, Westhoff CL. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Gynecol. 2001;14:3–8
  13. Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol. 2006;108:428–441
  14. Edwards JE, Moore RA, McQuay HJ. Rofecoxib for dysmenorrhoea: Meta-analysis using individual patient data. BMC Womens Health. 2004;4:5
  15. El-Gilany AH, Badawi K, El-Fedawy S. Epidemiology of dysmenorrhoea among adolescent students in Mansoura, Egypt. East Mediterr Health J. 2005;11:155–163
  16. Fedele L, Marchini M, Acaia B, Garagiola U, Tiengo M. Dynamics and significance of placebo response in primary dysmenorrhoea. Pain. 1989;36:43–47
  17. French L. Dysmenorrhea. Am Fam Physician. 2005;71:285–291
  18. Frolich JC. A classification of NSAIDs according to their relative inhibition of cyclooxygenase isoenzymes. Trends Pharmacol Sci. 1997;18:30–34
  19. Funk CD. Prostaglandins and leukotrienes: Advances in eicosanoid biology. Science. 2001;294:1871–1875
  20. Harel Z. A contemporary approach to dysmenorrhea in adolescents. Paediatr Drugs. 2002;4:797–805
  21. Harel Z. Dysmenorrhea in adolescents and young adults: Etiology and management. J Pediatr Adolesc Gynecol. 2006;19:363–371
  22. Hillen TI, Grbavac SL, Johnston PJ, Straton JA, Keogh JM. Primary dysmenorrhea in young Western Australian women: Prevalence, impact, and knowledge of treatment. J Adolesc Health. 1999;25:40–45
  23. Hoffman MD, Shepanski MA, Mackenzie SP, Clifford PS. Experimentally induced pain perception is acutely reduced by aerobic exercise in people with chronic low back pain. J Rehabil Res Dev. 2005;42:183–190
  24. Hoffman MD, Shepanski MA, Ruble SB, Valic Z, Buckwalter JB, Clifford PS. Intensity and duration threshold for aerobic exercise-induced analgesia to pressure pain. Arch Phys Med Rehabil. 2004;85:1183–1187
  25. Houston AM, Abraham A, Huang Z, D'Angelo LJ. Knowledge, attitudes, and consequences of menstrual health in urban adolescent females. J Pediatr Adolesc Gynecol. 2006;19:271–275
  26. Janse de Jonge XAK. Effects of menstrual cycle on exercise performance. Sports Med. 2003;33:833–851
  27. Klein JR, Litt IF. Epidemiology of adolescent dysmenorrhea. Pediatrics. 1981;68:661–664
  28. Koltyn KF, Garvin AW, Gardiner RL, Nelson TF. Perception of pain following aerobic exercise. Med Sci Sports Exerc. 1996;28:1418–1421
  29. Lebrun CM. Effect of different phases of the menstrual cycle and oral contraceptives on athletic performance. Sports Med. 1993;16:400–430
  30. Lee LK, Chen PC, Lee KK, Kaur J. Menstruation among adolescent girls in Malaysia: A cross-sectional school survey. Singapore Med J. 2006;47:869–874
  31. Majoribanks J, Proctor M, Farquhar C. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhea. Cochrane Database Syst Rev. 2003;4:CD001751
  32. McArdle W, Katch F, Katch V. Evaluating energy-generating capacities during exercise, in Essentials of Exercise Physiology. In: Philadelphia, PA: Lippincott Williams and Wilkins; 2000;p. 192
  33. Nigam S, Benedetto C, Zonca M, Leo-Rossberg I, Lubbert H, Hammerstein J. Increased concentrations of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhoea. Eicosanoids. 1991;4:137–141
  34. O'Connell K, Davis AR, Westhoff C. Self-treatment patterns among adolescent girls with dysmenorrhea. J Pediatr Adolesc Gynecol. 2006;19:285–289
  35. Patel V, Tanksale V, Sahasrabhojanee M, Gupte S, Nevrekar P. The burden and determinants of dysmenorrhoea: A population-based survey of 2262 women in Goa, India. BJOG. 2006;113:453–463
  36. Proctor M, Farquhar C. Dysmenorrhoea. Clin Evidence. 2002;7:1639–1653
  37. Sundell G, Milsom I, Andersch B. Factors influencing the prevalence and severity of dysmenorrhoea in young women. BJOG. 1990;97:588–594
  38. Tangchai K, Titapant V, Boriboonhirunsarn D. Dysmenorrhoea in Thai adolescents: Prevalence, impact and knowledge of treatment. J Med Assoc Thai. 2004;87:S69–S73

 Supported by a Faculty Research Committee Individual Grant (University of Witwatersrand) and by the National Research Foundation, South Africa.

 None of the authors has a financial interest in the research, and no funding was received from any pharmaceutical companies.

PII: S1526-5900(08)00733-5

doi: 10.1016/j.jpain.2008.08.006

The Journal of Pain
Volume 10, Issue 2 , Pages 191-200 , February 2009

Article Tools

* Image Usage & Resolution